HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other

Journal of Virology

Volumn 74, Issue 11, 2000, Pages 5291-5299

  Goulder, Philip J R ^a,b   Tang, Yanhua ^a   Pelton, Stephen I ^c   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; HLA B ANTIGEN; LAMIVUDINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; STAVUDINE;

ADOLESCENT; ARTICLE; CHILD; CYTOTOXIC T LYMPHOCYTE; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; AMINO ACID SEQUENCE; CHILD; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0034105485     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.11.5291-5299.2000     Document Type: Article

References (37)

1. Allen, T. M., J. Sidney, M. F. del Guerico, R. L. Glickman, G. L. Lensmeye, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, and D. I. Walkins. 1998. Characterization of the peptide-binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV. J. Immunol. 160:6062-6071.
2. Altman, J., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1995. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 274:94-96.
3. Androlewicz, M. J., and P. Cresswell. 1996. How selective is the transporter associated with antigen processing? Immunity 5:1-5.
4. Barber, L. D., L. Percival, K. L. Arnett, J. E. Gumperz, L. Chen, and P. Parham. 1997. Polymorphism in the a1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J. Immunol. 158:1660-1669.
5. Brander, C., and B. D. Walker. 1998. The HLA class I restricted CTL response in HIV infection: systematic identification of optimal epitopes. In B. T. M. Korber, C. Brander, B. D. Walker, R. A. Koup, J. Moore, B. Haynes, and G. Meyers (ed.), HIV molecular immunology database. Los Alamos National Laboratory, Los Alamos, N. Mex.
6. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. Browning, P. Morris, and K. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 hy PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355-67.
7. Carrington, M., G. W. Nelson, M. P. Martin, T. Kissner, D Vlahov, J. J. Goedert, R. Kaslow, S. Buchbinder, K. Hoots, and S. J. O'Brien. 1999. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage, Science 283:1748-1752.
8. Cerundolo, V., T. Elliott, J. Elvin, J. Bastin, H.-G. Rammensee, and A. R. M. Townsend. 1991. The binding affinity and dissociation rates of peptides for class 1 major histocompatibility complex molecules. Eur. J. Immunol. 21:2069.
9. Charron, D. (ed.). 1997. Proceedings of the twelfth international histocompatibility workshop and conference. EDK, Paris, France.
10. Dhodapkar, M. V., R. M. Steinman, M. Sapp, H. Desai, C. Fossella, J. Krasovsky, S. M. Donahoe, P. R. Dunbar, V. Cerundolo, D. F. Nixon, and N. Bhardwaj. 1999. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104:173-180.
11. Gallimore, A., T. Dumrese, H. Hengartner, R. M. Zinkernagel, and H.-G. Rammensee. 1998. Protective immunity does not correlate with the hierarchy of virus-specific CTL responses to naturally processed peptides. J. Exp. Med. 187:1647-1657.
12. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. M. Zinkernagel. 1998. Induction and exhaustion of ymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383-1393.
13. Goulder, P. J. R., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. L. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
14. Goulder, P. J. R., C. Brander, K. Annamalai, N. Mngqundaniso, U. Govender, Y. Tang, S. He, K. E. Hartman, C. A. O'Callaghan, G. S. Ogg, M. A. Altfeld, E. S. Rosenberg, H. Cao, S. A. Kalams, M. G. Hammond, M. Bunce, S. I. Pelton, S. A. Burchett, K. McIntosh, H. M. Coovadia, and B. D. Walker. Differential narrow focusing of immunodominant human immunodeficiency virus Gag-specific cytotoxic T-lymphocyte responses in infected African and Caucasoid adults and children. J. Virol., in press.
15. Goulder, P. J. R., S. Crowley, P. Krausa, B. Morgan, A. Edwards, P. Giangrande, K. McIntyre, and A. J. McMichael. 1996. Novel, cross-restricted, conserved and immunodominant CTL epitopes in long-term slow progressons in HIV-1 infection. AIDS Res. Hum. Retroviruses 12:1691-1698.
16. Goulder, P. J. R., S. W. Reid, D. A. Price, C. A. O'Callaghan, A. J. McMichael, R. E. Phillips, and E. Y. Jones. 1997. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur. J. Immunol. 27:1515-1521.
17. Guo, H. C., T. S. Jardetzky, T. P. Garrett, W. S. Lane, J. L. Strominger, and D. C. Wiley. 1992. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364-366.
18. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R. P. Johnson, S. Buchbinder, and B. D. Walker. 1996. Recognition of the highly conserved YMDD region in HIV-1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term non-progressor. J. Infect. Dis. 173:476-479.
19. Hay, M., D. J. Ruhl, N. Basgoz, C. C. Wilson, J. M. Billingsley, M. P. DePasquale, R. D'Aquila, S. Wolinsky, J. M. Crawford, D. Montefiori, and B. D. Walker. 1999. Lack of viral escape and defective in vivo activation of HIV-1-specific CTL in rapidly progressive infection. J. Virol. 73:5509-5519.
20. Hill, A. B., S. P. Lee, J. S. Haurum, N. Murray, Q. V. Yao, M. Rowe, N. Signoret, A. B. Rickinson, and A. J. McMichael. 1995. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell line against which they were raised. J. Exp. Med. 181:2221-2228.
21. Hill, A. V. S. 1998. The immunogenetics of human infectious disease. Annu. Rev. Immunol. 16:593-618.
22. Horig, H., A. C. M. Young, N. J. Papadopoulos, T. P. DiLorenzo, and S. G. Nathenson. 1999. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria. J. Immunol. 163:4434-4441.
23. Jeffrey, J. M., K. Usuku, S. E. Hall, W. Matsumoto, G. M. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, A. L. Lloyd, M. A. Nowak, M. Nagai, D. Kodama, S. Izumo, M. Osame, and C. R. M. Bangham. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-1-associated myelopathy. Proc. Natl. Acad. Sci. USA 96:3848-3853.
24. Kalams, S. A., R. P. Johnson, M. J. Dynan K. E. Hartman, T. Harrer, E. Harrer, A. Trocha, W. A. Blattner, S. P. Buchbinder, and B. D. Walker. 1996. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J. Exp. Med. 183:1669-1679.
25. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. R. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Ehrlich, and D. Mann. 1996. Influence of human MHC genes on the course of HIV infection. Natl. Med. 2:405-411.
26. Keet, I. P., J. Tang, M. Klein, S. LeBlanc, C. Enger, C. Rivers, R. J. Apple, D. Mann, J. J. Goedert, F. Miedema, and R. A. Kaslow. 1999. Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J. Infect. Dis. 180:299-309.
27. Klein, M. R., S. H. van der Burg, E. Hovenkamp, A. M. Holwerda, J. W. Drijfhout, C. J. Melief, and F. Miedema. 1998. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J. Gen. Virol. 79:2191-2201.
28. Lalvani, A., R. Brookes, S. Hambleton, W. J. Britton, A. V. S. Hill, and A. J. McMichael. 1997. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:859-865.
29. McAdam, S., P. Klenerman, L. Tussey, S. Rowland-Jones, D. Lalloo, R. Phillips, A. Edwards, P. Giangrande, A. L. Brown, F. M. Gotch, and A. J. McMichael. 1995. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J. Immunol. 155: 2729-2736.
30. Rock, K. I., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17: 739-780.
31. Schmitz, J. E., M. Kuroda, S. Santra, V. Sasseville, M. Simon, M. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. Scallon, J. Ghrayeb, M. Forman, D. Montefiori, E. Rieber, N. Letvin, and K. Reimann. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 277:333-338.
32. Tussey, L. G., S. Rowland-Jones, T. S. Zheng, M. J. Androlewicz, P. Cresswell, J. Frelinger, and A. J. McMichael. 1995. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65-77.
33. Van Baalen, C. A., M. Schutten, R. C. Huisman, P. H. Boers, R. A. Gruters, and A. D. Osterhaus. 1998. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J. Virol. 72:6851-6857.
34. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989 Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514-9518.
35. Walker, B. D. 1990. HIV-1-specific cytotoxic T lymphocytes, p. 201. In A. Aldovini and B. D. Walker (ed.). Techniques in HIV research. Stockton Press, New York, N. Y.
36. Yang, O. O., S. A. Kalams, M. Rosenzweig, A. Trocha, N. Jones, M. Koziel, B. D. Walker, and R. P. Johnson. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70:5799-5806.
37. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. D. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.